Neuphoria Therapeutics Inc. ( NEUP) - Stock Earnings
NEUP Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Sept. 2, 2026, midnight | — / — | — | — / — | — |
NEUP Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -15.0 million USD | — USD |
| 2025Q4 | 2.8 million USD | — USD |
| 2026Q1 | -505063 USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
NEUP Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -32.2 million USD | — USD |
| 2024 | -23.2 million USD | — USD |
| 2025 | -369632 USD | 15.6 million USD |
| 2026 Est. | — | — |
NEUP
Price: $3.91
52 week price:
Earnings Per Share: -7.90 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 20.8 million